LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
MCF7 Trametinib
0.04
uM
LJP5
3
P24
72
hr
1209 2376 4093 0.5805 0.4045
MCF7 Trametinib
0.04
uM
LJP5
2
P24
72
hr
1209 2145 4093 0.5241 0.3244
BT-20 Trametinib
0.04
uM
LJP5
1
P24
72
hr
1097 2687 3769 0.7128 0.5949
MDA-MB-231 Trametinib
0.04
uM
LJP5
1
P24
72
hr
1235 1366 4513 0.3026 0.0397
MCF 10A Trametinib
0.04
uM
LJP5
1
P24
72
hr
962 1801 10605 0.1698 0.0870
MDA-MB-231 XMD11-85h
0.04
uM
LJP6
3
P24
72
hr
1235 4089 4513 0.9059 0.8704
Hs 578T Trametinib
0.04
uM
LJP5
1
P24
72
hr
658 1127 3846 0.2930 0.1471
MDA-MB-231 XMD11-85h
0.04
uM
LJP6
2
P24
72
hr
1235 3689 4513 0.8173 0.7484
MCF 10A Trametinib
0.04
uM
LJP5
3
P24
72
hr
962 1576 10605 0.1486 0.0637
MDA-MB-231 XMD11-85h
0.04
uM
LJP6
1
P24
72
hr
1235 3343 4513 0.7406 0.6429
Hs 578T Trametinib
0.04
uM
LJP5
2
P24
72
hr
658 1050 3846 0.2730 0.1229
MCF7 Trametinib
0.04
uM
LJP5
1
P24
72
hr
1209 2044 4093 0.4994 0.2894
MCF7 XMD11-85h
0.04
uM
LJP6
1
P24
72
hr
1209 3667 4093 0.8959 0.8523
MCF7 XMD11-85h
0.04
uM
LJP6
2
P24
72
hr
1209 3276 4093 0.8004 0.7167
BT-20 Trametinib
0.04
uM
LJP5
2
P24
72
hr
1097 3198 3769 0.8484 0.7861
MCF7 XMD11-85h
0.04
uM
LJP6
3
P24
72
hr
1209 3379 4093 0.8256 0.7524
SK-BR-3 XMD11-85h
0.04
uM
LJP6
3
P24
72
hr
1401 3297 4223 0.7807 0.6718
SK-BR-3 XMD11-85h
0.04
uM
LJP6
2
P24
72
hr
1401 3062 4223 0.7251 0.5885
BT-20 Trametinib
0.04
uM
LJP5
3
P24
72
hr
1097 3250 3769 0.8622 0.8056
SK-BR-3 XMD11-85h
0.04
uM
LJP6
1
P24
72
hr
1401 3393 4223 0.8034 0.7058